James C. Foster - 31 May 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Chairman, President and CEO, Director
Signature
/s/ James C. Foster
Issuer symbol
CRL
Transactions as of
31 May 2024
Net transactions value
+$5,181,402
Form type
4
Filing time
04 Jun 2024, 16:19:35 UTC
Previous filing
30 May 2024
Next filing
05 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRL Common Stock 7,580 31 May 2024 2022 GRAT
holding CRL Common Stock 20,000 31 May 2024 2023 GRAT
holding CRL Common Stock 223,044 31 May 2024 Direct
holding CRL Common Stock 2,250 31 May 2024 By Trust
holding CRL Common Stock 750 31 May 2024 By Trust
holding CRL Common Stock 340 31 May 2024 By Trust
holding CRL Common Stock 10,000 31 May 2024 Held By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $5,181,402 +24,858 $208.44 24,858 31 May 2024 Common Stock 24,858 $208.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: 6,214 on May 31, 2025, 6,215 on May 31, 2026, 6,214 on May 31, 2027, and 6,215 on May 31, 2028.